Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
Authors
Keywords
Cancer–testis antigens, Esophageal cancer, MAGE-A, NY-ESO-1, LAGE-1, TTK
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-17
DOI
10.1007/s00432-019-02840-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MAGE-A antigens as targets for cancer immunotherapy
- (2018) Erik Schooten et al. CANCER TREATMENT REVIEWS
- Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK2 Inhibitor for Treatment of Triple-negative Breast Cancer with a Compromised G1/S Checkpoint
- (2018) Dan Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer
- (2018) K. L. Thu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer
- (2018) Xiangling Chen et al. Theranostics
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
- (2018) Olga Gordeeva SEMINARS IN CANCER BIOLOGY
- TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer
- (2018) Jamie L. King et al. Oncogenesis
- Gene set enrichment analysis and meta-analysis to identify six key genes regulating and controlling the prognosis of esophageal squamous cell carcinoma
- (2018) Wenwu He et al. Journal of Thoracic Disease
- Promising immunotherapies for esophageal cancer
- (2017) Tomokazu Tanaka et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3
- (2017) Yong-Chen Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen
- (2017) Jennifer R. Riggs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
- (2017) A Szymiczek et al. ONCOGENE
- Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer
- (2017) Jacqueline M. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray
- (2016) Meixiang Sang et al. ARCHIVES OF MEDICAL RESEARCH
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer
- (2016) Ruoyu Miao et al. Scientific Reports
- Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model
- (2015) A. R. R. Maia et al. ANNALS OF ONCOLOGY
- Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
- (2015) S. Kageyama et al. CLINICAL CANCER RESEARCH
- NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
- (2015) Yoko Oshima et al. JOURNAL OF GASTROENTEROLOGY
- Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer
- (2015) Jean-Louis Pujol et al. Journal of Thoracic Oncology
- Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells
- (2014) B P Kaistha et al. BRITISH JOURNAL OF CANCER
- Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
- (2014) Aaron P. Rapoport et al. CLINICAL CANCER RESEARCH
- Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients
- (2014) Hisae Iinuma et al. Journal of Translational Medicine
- Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development
- (2014) Mohammad Mahdi Forghanifard et al. MEDICAL ONCOLOGY
- Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens
- (2014) Stephen J Hayes WORLD JOURNAL OF GASTROENTEROLOGY
- Assessment of MAGE-A Expression in Resected Non-Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of EGFR and KRAS
- (2014) M. Ayyoub et al. Cancer Immunology Research
- Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
- (2013) Angelique W. Whitehurst Annual Review of Pharmacology and Toxicology
- Derepression of Cancer/Testis Antigens in cancer is associated with distinct patterns of DNA Hypomethylation
- (2013) Robert Kim et al. BMC CANCER
- Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma
- (2013) Phyu P. Aung et al. HUMAN PATHOLOGY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results
- (2013) Johan Vansteenkiste et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs
- (2013) Bakhos A. Tannous et al. JNCI-Journal of the National Cancer Institute
- Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
- (2013) Shinichi Kageyama et al. Journal of Translational Medicine
- Cancer-Testis Antigen Expression in Digestive Tract Carcinomas: Frequent Expression in Esophageal Squamous Cell Carcinoma and Its Precursor Lesions
- (2013) Y.-T. Chen et al. Cancer Immunology Research
- Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
- (2012) Emmet McCormack et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MAGE-A antigens as targets in tumour therapy
- (2012) David W. Meek et al. CANCER LETTERS
- A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer
- (2012) Qiang Shan et al. CANCER LETTERS
- First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
- (2012) Norihiko Takahashi et al. CANCER SCIENCE
- MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas
- (2012) Chantal Mengus et al. INTERNATIONAL JOURNAL OF CANCER
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Identification of Distinct Gene Expression Profiles between Esophageal Squamous Cell Carcinoma and Adjacent Normal Epithelial Tissues
- (2012) Yisheng Tao et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: Identification of specific tumor marker and potential targets for immunotherapy
- (2011) Mohammad Mahdi Forghanifard et al. CANCER BIOLOGY & THERAPY
- Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
- (2011) M. Rao et al. CANCER RESEARCH
- T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice
- (2011) Yoshitaka Shirakura et al. CANCER SCIENCE
- MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma
- (2011) T. Bujas et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
- (2011) Kazuhiro Kakimi et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma
- (2011) Sofie Wilgenhof et al. JOURNAL OF IMMUNOTHERAPY
- The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
- (2011) Elisabetta Fratta et al. Molecular Oncology
- Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma
- (2010) Makoto Iwahashi et al. CANCER SCIENCE
- Immunobiomarkers in Small Cell Lung Cancer: Potential Early Cancer Signals
- (2010) Caroline J. Chapman et al. CLINICAL CANCER RESEARCH
- Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma
- (2010) Cyril Cuffel et al. INTERNATIONAL JOURNAL OF CANCER
- MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies
- (2010) Elke Schultz-Thater et al. INTERNATIONAL JOURNAL OF CANCER
- Epitope Hierarchy of Spontaneous CD4+ T Cell Responses to LAGE-1
- (2010) P. Kudela et al. JOURNAL OF IMMUNOLOGY
- Prediction and analysis of HLA-A2/A24-restricted cytotoxic T-lymphocyte epitopes of the tumor antigen MAGE-n using the artificial neural networks method on NetCTL1.2 Server
- (2010) XIU-MIN ZHANG et al. Oncology Letters
- Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma
- (2010) Benjamin Piura et al. Journal of Oncology
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients
- (2009) A. Bonehill et al. CLINICAL CANCER RESEARCH
- MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy
- (2009) Preeta Tyagi et al. Clinical Lung Cancer
- Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma
- (2008) Yoshiki Mizukami et al. CANCER SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started